NGM313, a Novel Activator of β-Klotho/FGFR1c, Improves Insulin Resistance and Reduces Hepatic Fat in Obese, Nondiabetic Subjects

in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?

I'm interested in receiving: